Press Releases on September 6, 2016 - EIN Presswire - Press Release Distribution Service

Published on September 6, 2016 - 11:17 GMT

BioMotiv and Biogen Expand Strategic Partnership Into Ophthalmology

BioMotiv, LLC, the therapeutic accelerator company associated with The Harrington Project for Discovery & Development centered at University Hospitals in Cleveland, Ohio, announced today that it has expanded its strategic partnership with Biogen to …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry

Published on September 6, 2016 - 11:09 GMT

Colfax to Host Annual Investor Event

Annapolis Junction, MD, Sept. 06, 2016 (GLOBE NEWSWIRE) -- Colfax Corporation ("Colfax") (NYSE: CFX), a leading global manufacturer of gas- and fluid-handling and fabrication technology products, will host its Annual Investor Day on September 13, …

Distribution channels: Conferences & Trade Fairs, Technology

Published on September 6, 2016 - 11:05 GMT

Matinas BioPharma to Present at the 18th Annual Rodman & Renshaw Global Investment Conference in New York City on September 13, ...

BEDMINSTER, N.J., Sept. 06, 2016 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (OTCQB:MTNB), a clinical-stage biopharmaceutical company focused on identifying and developing safe and effective broad spectrum therapeutics for the treatment of serious …

Distribution channels: Conferences & Trade Fairs, Healthcare & Pharmaceuticals Industry

Published on September 6, 2016 - 11:00 GMT

Inspyr Therapeutics Announces Mipsagargin Ph 2 Trial for Patients with Clear Cell Renal Cell Carcinoma Expressing PSMA

Second Investigator-Sponsored Trial for Mipsagargin being conducted at The University of Texas Health Science Center Inspyr Therapeutics, Inc. (OTCQB:NSPX) SAN ANTONIO, TX, UNITED STATES, September 6, 2016 /EINPresswire.com/ -- Inspyr Therapeutics, Inc. …

Distribution channels: Agriculture, Farming & Forestry Industry, Banking, Finance & Investment Industry ...

Published on September 6, 2016 - 11:00 GMT

EJL Wireless Research Reports Global BTS Antenna Shipments Achieve Another Record Year in 2015

Antenna shipments up 2% while revenues increased 5% in 2015 to USD $3.5 billion; Massive MIMO active antennas will drive revenues to USD $14 billion by 2020 SALEM, NH, UNITED STATES, September 6, 2016 /EINPresswire.com/ -- The global BTS antenna …

Distribution channels: Banking, Finance & Investment Industry, Electronics Industry ...

Published on September 6, 2016 - 10:59 GMT

REMINDER/Media Advisory: Government of Canada Announces Recipients of the Canada First Research Excellence Fund

WATERLOO, ONTARIO -- (Marketwired) -- 09/06/16 -- The Honourable Kirsty Duncan, Minister of Science, will announce the recipients of the second competition of the Canada First Research Excellence Fund (CFREF) during an official ceremony at the University …

Distribution channels: Politics, U.S. Politics

Published on September 6, 2016 - 10:59 GMT

Pure Gold Intersects 50.2 g/t Gold Over 4.0 Metres at the McVeigh Horizon, Madsen Gold Project

Pure Gold Mining Inc. (TSX VENTURE:PGM) ("Pure Gold" or the "Company") is pleased to announce additional drill results from the ongoing 51,000 metre drill program at the Company's 100% owned Madsen Gold Project ("Madsen"). …

Distribution channels: Mining Industry

Published on September 6, 2016 - 11:00 GMT

Enbridge and Spectra Energy to Combine to Create North America's Premier Energy Infrastructure Company with C$165 Billion ...

Highlights: Creates largest energy infrastructure company in North America with C$1651 billion (US$127 billion) enterprise value Anticipated 15 percent annualized dividend increase in 2017 and annual 10-12 percent dividend growth thereafter through 2024. …

Distribution channels: Energy Industry

Published on September 6, 2016 - 11:00 GMT

Codexis to Present at September Investment Conferences

REDWOOD CITY, Calif., Sept. 06, 2016 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that management will present at three upcoming investment conferences: Rodman & Renshaw 18th Annual Global Investment …

Distribution channels: Conferences & Trade Fairs, Healthcare & Pharmaceuticals Industry

Published on September 6, 2016 - 11:00 GMT

Capnia to Present at Upcoming Investor Conferences

REDWOOD CITY, Calif., Sept. 06, 2016 (GLOBE NEWSWIRE) -- Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops and commercializes innovative diagnostics, devices and therapeutics addressing unmet medical needs, today announced that …

Distribution channels: Conferences & Trade Fairs, Healthcare & Pharmaceuticals Industry

Published on September 6, 2016 - 11:00 GMT

Zynerba Pharmaceuticals Launches Phase 2 Clinical Trial of ZYN002 CBD Gel for Treatment of Osteoarthritis

DEVON, Pa., Sept. 06, 2016 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to the development of innovative transdermal synthetic cannabinoid treatments, today announced that it …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on September 6, 2016 - 11:00 GMT

Recro Pharma to Present at the Rodman & Renshaw 18th Annual Global Investment Conference

MALVERN, Pa., Sept. 06, 2016 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on products for hospital and ambulatory care settings, currently developing non-opioid products for the …

Distribution channels: Conferences & Trade Fairs, Healthcare & Pharmaceuticals Industry

Published on September 6, 2016 - 11:00 GMT

Nabriva to Present at the Rodman & Renshaw 18th Annual Global Investment Conference

VIENNA, Austria and KING OF PRUSSIA, Pa., Sept. 06, 2016 (GLOBE NEWSWIRE) -- Nabriva Therapeutics AG (NASDAQ:NBRV), a clinical stage biopharmaceutical company engaged in the research and development of novel anti-infective agents to treat serious …

Distribution channels: Conferences & Trade Fairs, Healthcare & Pharmaceuticals Industry

Published on September 6, 2016 - 11:00 GMT

Apricus Biosciences Announces the Launch of Its Novel Topical Treatment for Erectile Dysfunction in Portugal, Ireland and Poland ...

SAN DIEGO, Sept. 06, 2016 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced the launch of Vitaros®, Apricus’ novel on-demand topical cream …

Distribution channels: Technology

Published on September 6, 2016 - 11:00 GMT

Horizon Pharma plc to Participate in Morgan Stanley Global Healthcare Conference

DUBLIN, Ireland, Sept. 06, 2016 (GLOBE NEWSWIRE) -- Horizon Pharma plc (Nasdaq:HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines …

Distribution channels: Conferences & Trade Fairs, Healthcare & Pharmaceuticals Industry

Published on September 6, 2016 - 11:00 GMT

Collegium Announces the Launch of OpioidIQ

CANTON, Mass., Sept. 06, 2016 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (NASDAQ:COLL) announces the launch of OpioidIQ, an online educational tool to assist physicians and other healthcare providers with more effective pain management (Available …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on September 6, 2016 - 11:00 GMT

Mitek Announces b-Sharpe Has Selected Mobile Verify for Identity Verification

SAN DIEGO and LONDON, Sept. 06, 2016 (GLOBE NEWSWIRE) -- Mitek (NASDAQ:MITK) (www.miteksystems.com), a global leader in mobile capture and identity verification software solutions, today announced that the online foreign currency exchange b-Sharpe has …

Distribution channels: IT Industry

Published on September 6, 2016 - 11:00 GMT

Advanced Accelerator Applications Announces Two Phase II Studies Evaluating 99MrhAnnexin V-128 Imaging in Cardiovascular and ...

SAINT-GENIS-POUILLY, France, Sept. 06, 2016 (GLOBE NEWSWIRE) -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (“AAA” or the “Company”), an international specialist in Molecular Nuclear Medicine (MNM), today announced the initiation of two Phase II …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on September 6, 2016 - 11:00 GMT

CoLucid Pharmaceuticals Announces Achievement of Both Primary and Key Secondary Endpoints in the SAMURAI Phase 3 Pivotal Trial of ...

100 mg and 200 mg doses of lasmiditan efficacious on headache pain freedom and most bothersome symptom free at the two-hour time point (p < 0.001) Lasmiditan was well tolerated with no significant difference in cardiovascular adverse events in patients …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on September 6, 2016 - 11:00 GMT

Karyopharm Reports Positive Top-Line Phase 2b STORM Results and Reviews the Planned Development Path for Selinexor in Multiple ...

- Selinexor Achieves Promising Response Rates in Patients with Multiple Myeloma, Including 20.8% in Quad-Refractory and 20.0% in Penta-Refractory Disease - - Expanding Phase 2b STORM Study to Include Approximately 120 Additional Patients with Penta- …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry